Big Fly in the Ointment Having said all of that there is a big fly in the ointment for the whole industry, one that keeps getting fatter. Intel now holds one of the most enviable graphics patent portfolios in the business. Only Evans and Sutherland can boast its equal, and they haven't done much with theirs in the PC industry lately. No such luck for Intel's competitors. Then Intel let go of the staff.
Jobs are open for evaluation.
Intel gains by getting Real3D's extensive patent portfolio and potentially is better able to compete in the 3D market. In the last response to those who stayed on to the end, the Real3D options were not converted to Intel stock or options. A sad tribute to those who tried in a company that could not last 2 years. In simple terms, Intel has many, many years worth of graphics technology that it can simply squeeze into its components and chipsets, and it doesn't have to go out and re-invent the wheel to do it. In fact, Intel can scare off any graphics company that tries to close in on it by just waiving a handful of patents, and that's that.